GEODE CAPITAL MANAGEMENT, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 108 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$37,239,263
-17.0%
809,626
+3.8%
0.00%
-20.0%
Q2 2023$44,841,503
+57.3%
780,259
+2.7%
0.01%
+25.0%
Q1 2023$28,499,300
+140720.7%
759,981
+5.2%
0.00%
+33.3%
Q4 2022$20,238
-99.9%
722,281
+2.0%
0.00%0.0%
Q3 2022$19,900,000
-17.4%
708,206
+2.3%
0.00%
-25.0%
Q2 2022$24,088,000
-4.6%
692,388
-1.6%
0.00%
+33.3%
Q1 2022$25,254,000
+51.7%
703,479
-1.6%
0.00%
+50.0%
Q4 2021$16,649,000
+24.4%
714,873
+1.6%
0.00%0.0%
Q3 2021$13,381,000
-3.7%
703,915
+2.2%
0.00%0.0%
Q2 2021$13,891,000
+14.8%
689,084
+4.3%
0.00%0.0%
Q1 2021$12,098,000
+4.8%
660,413
+15.0%
0.00%0.0%
Q4 2020$11,546,000
+13.6%
574,144
+5.9%
0.00%0.0%
Q3 2020$10,167,000
-16.2%
542,267
+0.3%
0.00%
-33.3%
Q2 2020$12,139,000
+53.2%
540,520
+1.2%
0.00%
+50.0%
Q1 2020$7,925,000
-59.3%
534,078
-47.1%
0.00%0.0%
Q4 2019$19,476,000
+99.6%
1,009,656
+105.2%
0.00%0.0%
Q3 2019$9,756,000
-4.5%
492,021
+1.6%
0.00%0.0%
Q2 2019$10,221,000
+12.5%
484,212
+8.9%
0.00%0.0%
Q1 2019$9,082,000
-46.3%
444,578
-47.7%
0.00%
-33.3%
Q4 2018$16,924,000
+126.4%
850,602
+118.9%
0.00%
+50.0%
Q3 2018$7,475,000
+28.6%
388,517
+2.0%
0.00%0.0%
Q2 2018$5,811,000
-9.2%
380,859
+11.5%
0.00%0.0%
Q1 2018$6,402,000
-0.0%
341,466
+2.6%
0.00%0.0%
Q4 2017$6,403,000
+9.5%
332,824
+1.7%
0.00%0.0%
Q3 2017$5,850,000
+2.7%
327,389
+2.6%
0.00%0.0%
Q2 2017$5,697,000
+9.1%
319,031
-11.4%
0.00%0.0%
Q1 2017$5,221,000
-15.7%
360,078
+7.0%
0.00%
-33.3%
Q4 2016$6,195,000
-9.6%
336,369
-6.9%
0.00%0.0%
Q3 2016$6,850,000
+42.5%
361,152
+21.1%
0.00%0.0%
Q2 2016$4,808,000
+42.5%
298,297
+6.0%
0.00%
+50.0%
Q1 2016$3,375,000
-9.7%
281,280
+7.1%
0.00%0.0%
Q4 2015$3,736,000
+57.9%
262,600
+29.7%
0.00%
+100.0%
Q3 2015$2,366,000
+46.5%
202,460
+120.3%
0.00%0.0%
Q2 2015$1,615,000
+43.6%
91,885
+22.1%
0.00%0.0%
Q1 2015$1,125,000
+111.1%
75,254
+63.8%
0.00%
Q4 2014$533,000
+28.4%
45,940
+28.7%
0.00%
Q3 2014$415,00035,7090.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders